Close Menu

In the wake of safety questions over GlaxoSmithKline's Avandia, FDA is recommending more rigorous testing of diabetes drugs for heart attack and stroke risk. The new recommendations are effective immediately, reports the Wall Street Journal, and they suggest that clinical trials should be redesigned with heart attack and stroke risk assessment in mind, and that any cardiovascular events that occur during the trial should be reviewed by independent, blinded cardiologists.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Seven individuals have been named to the President's Council of Advisors on Science and Technology, ScienceInsider reports.

Retraction Watch reports that a series of tweets led to expression of concern for a PLOS Genetics paper, a move the paper's authors disagree with.

Researchers have sequenced pumas from North and South America to enable better identification of inbreeding, Cosmos magazine reports.

In Nucleic Acids Research this week: ways to find cell death or proliferation signatures, Han Chinese population genome database, and more.